img

Global Specialty Pharmaceutical Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Specialty Pharmaceutical Market Insights, Forecast to 2034

Specialty pharmaceuticals are a recent designation of pharmaceuticals that are classified as high-cost, high complexity and/or high touch.
Market Analysis and InsightsGlobal Specialty Pharmaceutical Market
Global Specialty Pharmaceutical market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Specialty Pharmaceutical industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Specialty Pharmaceutical market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Specialty Pharmaceutical market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Pfizer
Roche
Amgen
AbbVie
Novo Nordisk
Johnson & Johnson
Sanofi-Aventis
Merck
Eli Lilly
Novartis
3sbio
Changchun High Tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Innovent
Segment by Type
Antibody
Hormone
Growth Factors
Other

Segment by Application


Tumor
Diabetes
Cardiovascular
Hemophilia
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Specialty Pharmaceutical introduction, etc. Specialty Pharmaceutical Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports’s Conclusions of Specialty Pharmaceutical
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Specialty Pharmaceutical Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Antibody
1.2.3 Hormone
1.2.4 Growth Factors
1.2.5 Other
1.3 Market by Application
1.3.1 Global Specialty Pharmaceutical Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Specialty Pharmaceutical Market Perspective (2018-2029)
2.2 Global Specialty Pharmaceutical Growth Trends by Region
2.2.1 Specialty Pharmaceutical Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Specialty Pharmaceutical Historic Market Size by Region (2018-2024)
2.2.3 Specialty Pharmaceutical Forecasted Market Size by Region (2024-2029)
2.3 Specialty Pharmaceutical Market Dynamics
2.3.1 Specialty Pharmaceutical Industry Trends
2.3.2 Specialty Pharmaceutical Market Drivers
2.3.3 Specialty Pharmaceutical Market Challenges
2.3.4 Specialty Pharmaceutical Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Specialty Pharmaceutical by Players
3.1.1 Global Specialty Pharmaceutical Revenue by Players (2018-2024)
3.1.2 Global Specialty Pharmaceutical Revenue Market Share by Players (2018-2024)
3.2 Global Specialty Pharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Specialty Pharmaceutical, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Specialty Pharmaceutical Market Concentration Ratio
3.4.1 Global Specialty Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Specialty Pharmaceutical Revenue in 2022
3.5 Global Key Players of Specialty Pharmaceutical Head office and Area Served
3.6 Global Key Players of Specialty Pharmaceutical, Product and Application
3.7 Global Key Players of Specialty Pharmaceutical, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Specialty Pharmaceutical Breakdown Data by Type
4.1 Global Specialty Pharmaceutical Historic Market Size by Type (2018-2024)
4.2 Global Specialty Pharmaceutical Forecasted Market Size by Type (2024-2029)
5 Specialty Pharmaceutical Breakdown Data by Application
5.1 Global Specialty Pharmaceutical Historic Market Size by Application (2018-2024)
5.2 Global Specialty Pharmaceutical Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Specialty Pharmaceutical Market Size (2018-2029)
6.2 North America Specialty Pharmaceutical Market Size by Type
6.2.1 North America Specialty Pharmaceutical Market Size by Type (2018-2024)
6.2.2 North America Specialty Pharmaceutical Market Size by Type (2024-2029)
6.2.3 North America Specialty Pharmaceutical Market Share by Type (2018-2029)
6.3 North America Specialty Pharmaceutical Market Size by Application
6.3.1 North America Specialty Pharmaceutical Market Size by Application (2018-2024)
6.3.2 North America Specialty Pharmaceutical Market Size by Application (2024-2029)
6.3.3 North America Specialty Pharmaceutical Market Share by Application (2018-2029)
6.4 North America Specialty Pharmaceutical Market Size by Country
6.4.1 North America Specialty Pharmaceutical Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Specialty Pharmaceutical Market Size by Country (2018-2024)
6.4.3 North America Specialty Pharmaceutical Market Size by Country (2024-2029)
6.4.4 the United States
6.4.5 Canada
7 Europe
7.1 Europe Specialty Pharmaceutical Market Size (2018-2029)
7.2 Europe Specialty Pharmaceutical Market Size by Type
7.2.1 Europe Specialty Pharmaceutical Market Size by Type (2018-2024)
7.2.2 Europe Specialty Pharmaceutical Market Size by Type (2024-2029)
7.2.3 Europe Specialty Pharmaceutical Market Share by Type (2018-2029)
7.3 Europe Specialty Pharmaceutical Market Size by Application
7.3.1 Europe Specialty Pharmaceutical Market Size by Application (2018-2024)
7.3.2 Europe Specialty Pharmaceutical Market Size by Application (2024-2029)
7.3.3 Europe Specialty Pharmaceutical Market Share by Application (2018-2029)
7.4 Europe Specialty Pharmaceutical Market Size by Country
7.4.1 Europe Specialty Pharmaceutical Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Specialty Pharmaceutical Market Size by Country (2018-2024)
7.4.3 Europe Specialty Pharmaceutical Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Specialty Pharmaceutical Market Size (2018-2029)
8.2 China Specialty Pharmaceutical Market Size by Type
8.2.1 China Specialty Pharmaceutical Market Size by Type (2018-2024)
8.2.2 China Specialty Pharmaceutical Market Size by Type (2024-2029)
8.2.3 China Specialty Pharmaceutical Market Share by Type (2018-2029)
8.3 China Specialty Pharmaceutical Market Size by Application
8.3.1 China Specialty Pharmaceutical Market Size by Application (2018-2024)
8.3.2 China Specialty Pharmaceutical Market Size by Application (2024-2029)
8.3.3 China Specialty Pharmaceutical Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Specialty Pharmaceutical Market Size (2018-2029)
9.2 Asia Specialty Pharmaceutical Market Size by Type
9.2.1 Asia Specialty Pharmaceutical Market Size by Type (2018-2024)
9.2.2 Asia Specialty Pharmaceutical Market Size by Type (2024-2029)
9.2.3 Asia Specialty Pharmaceutical Market Share by Type (2018-2029)
9.3 Asia Specialty Pharmaceutical Market Size by Application
9.3.1 Asia Specialty Pharmaceutical Market Size by Application (2018-2024)
9.3.2 Asia Specialty Pharmaceutical Market Size by Application (2024-2029)
9.3.3 Asia Specialty Pharmaceutical Market Share by Application (2018-2029)
9.4 Asia Specialty Pharmaceutical Market Size by Region
9.4.1 Asia Specialty Pharmaceutical Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Specialty Pharmaceutical Market Size by Region (2018-2024)
9.4.3 Asia Specialty Pharmaceutical Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Type
10.2.1 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Application
10.3.1 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Country
10.4.1 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Specialty Pharmaceutical Introduction
11.1.4 Pfizer Revenue in Specialty Pharmaceutical Business (2018-2024)
11.1.5 Pfizer Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Specialty Pharmaceutical Introduction
11.2.4 Roche Revenue in Specialty Pharmaceutical Business (2018-2024)
11.2.5 Roche Recent Developments
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Specialty Pharmaceutical Introduction
11.3.4 Amgen Revenue in Specialty Pharmaceutical Business (2018-2024)
11.3.5 Amgen Recent Developments
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Specialty Pharmaceutical Introduction
11.4.4 AbbVie Revenue in Specialty Pharmaceutical Business (2018-2024)
11.4.5 AbbVie Recent Developments
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Details
11.5.2 Novo Nordisk Business Overview
11.5.3 Novo Nordisk Specialty Pharmaceutical Introduction
11.5.4 Novo Nordisk Revenue in Specialty Pharmaceutical Business (2018-2024)
11.5.5 Novo Nordisk Recent Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Specialty Pharmaceutical Introduction
11.6.4 Johnson & Johnson Revenue in Specialty Pharmaceutical Business (2018-2024)
11.6.5 Johnson & Johnson Recent Developments
11.7 Sanofi-Aventis
11.7.1 Sanofi-Aventis Company Details
11.7.2 Sanofi-Aventis Business Overview
11.7.3 Sanofi-Aventis Specialty Pharmaceutical Introduction
11.7.4 Sanofi-Aventis Revenue in Specialty Pharmaceutical Business (2018-2024)
11.7.5 Sanofi-Aventis Recent Developments
11.8 Merck
11.8.1 Merck Company Details
11.8.2 Merck Business Overview
11.8.3 Merck Specialty Pharmaceutical Introduction
11.8.4 Merck Revenue in Specialty Pharmaceutical Business (2018-2024)
11.8.5 Merck Recent Developments
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Specialty Pharmaceutical Introduction
11.9.4 Eli Lilly Revenue in Specialty Pharmaceutical Business (2018-2024)
11.9.5 Eli Lilly Recent Developments
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Specialty Pharmaceutical Introduction
11.10.4 Novartis Revenue in Specialty Pharmaceutical Business (2018-2024)
11.10.5 Novartis Recent Developments
11.11 3sbio
11.11.1 3sbio Company Details
11.11.2 3sbio Business Overview
11.11.3 3sbio Specialty Pharmaceutical Introduction
11.11.4 3sbio Revenue in Specialty Pharmaceutical Business (2018-2024)
11.11.5 3sbio Recent Developments
11.12 Changchun High Tech
11.12.1 Changchun High Tech Company Details
11.12.2 Changchun High Tech Business Overview
11.12.3 Changchun High Tech Specialty Pharmaceutical Introduction
11.12.4 Changchun High Tech Revenue in Specialty Pharmaceutical Business (2018-2024)
11.12.5 Changchun High Tech Recent Developments
11.13 CP Guojian Pharmacy
11.13.1 CP Guojian Pharmacy Company Details
11.13.2 CP Guojian Pharmacy Business Overview
11.13.3 CP Guojian Pharmacy Specialty Pharmaceutical Introduction
11.13.4 CP Guojian Pharmacy Revenue in Specialty Pharmaceutical Business (2018-2024)
11.13.5 CP Guojian Pharmacy Recent Developments
11.14 Biotech Pharma
11.14.1 Biotech Pharma Company Details
11.14.2 Biotech Pharma Business Overview
11.14.3 Biotech Pharma Specialty Pharmaceutical Introduction
11.14.4 Biotech Pharma Revenue in Specialty Pharmaceutical Business (2018-2024)
11.14.5 Biotech Pharma Recent Developments
11.15 Gelgen Biopharma
11.15.1 Gelgen Biopharma Company Details
11.15.2 Gelgen Biopharma Business Overview
11.15.3 Gelgen Biopharma Specialty Pharmaceutical Introduction
11.15.4 Gelgen Biopharma Revenue in Specialty Pharmaceutical Business (2018-2024)
11.15.5 Gelgen Biopharma Recent Developments
11.16 Innovent
11.16.1 Innovent Company Details
11.16.2 Innovent Business Overview
11.16.3 Innovent Specialty Pharmaceutical Introduction
11.16.4 Innovent Revenue in Specialty Pharmaceutical Business (2018-2024)
11.16.5 Innovent Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Specialty Pharmaceutical Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Antibody
Table 3. Key Players of Hormone
Table 4. Key Players of Growth Factors
Table 5. Key Players of Other
Table 6. Global Specialty Pharmaceutical Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Specialty Pharmaceutical Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Specialty Pharmaceutical Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Specialty Pharmaceutical Market Share by Region (2018-2024)
Table 10. Global Specialty Pharmaceutical Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Specialty Pharmaceutical Market Share by Region (2024-2029)
Table 12. Specialty Pharmaceutical Market Trends
Table 13. Specialty Pharmaceutical Market Drivers
Table 14. Specialty Pharmaceutical Market Challenges
Table 15. Specialty Pharmaceutical Market Restraints
Table 16. Global Specialty Pharmaceutical Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Specialty Pharmaceutical Revenue Share by Players (2018-2024)
Table 18. Global Top Specialty Pharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specialty Pharmaceutical as of 2022)
Table 19. Global Specialty Pharmaceutical Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Specialty Pharmaceutical Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Specialty Pharmaceutical, Headquarters and Area Served
Table 22. Global Key Players of Specialty Pharmaceutical, Product and Application
Table 23. Global Key Players of Specialty Pharmaceutical, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Specialty Pharmaceutical Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Specialty Pharmaceutical Revenue Market Share by Type (2018-2024)
Table 27. Global Specialty Pharmaceutical Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Specialty Pharmaceutical Revenue Market Share by Type (2024-2029)
Table 29. Global Specialty Pharmaceutical Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Specialty Pharmaceutical Revenue Share by Application (2018-2024)
Table 31. Global Specialty Pharmaceutical Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Specialty Pharmaceutical Revenue Share by Application (2024-2029)
Table 33. North America Specialty Pharmaceutical Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Specialty Pharmaceutical Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Specialty Pharmaceutical Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Specialty Pharmaceutical Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Specialty Pharmaceutical Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Specialty Pharmaceutical Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Specialty Pharmaceutical Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Specialty Pharmaceutical Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Specialty Pharmaceutical Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Specialty Pharmaceutical Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Specialty Pharmaceutical Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Specialty Pharmaceutical Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Specialty Pharmaceutical Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Specialty Pharmaceutical Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Specialty Pharmaceutical Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Specialty Pharmaceutical Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Specialty Pharmaceutical Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Specialty Pharmaceutical Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Specialty Pharmaceutical Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Specialty Pharmaceutical Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Specialty Pharmaceutical Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Specialty Pharmaceutical Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Specialty Pharmaceutical Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Specialty Pharmaceutical Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Specialty Pharmaceutical Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Specialty Pharmaceutical Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size by Country (2024-2029) & (US$ Million)
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Specialty Pharmaceutical Product
Table 68. Pfizer Revenue in Specialty Pharmaceutical Business (2018-2024) & (US$ Million)
Table 69. Pfizer Recent Developments
Table 70. Roche Company Details
Table 71. Roche Business Overview
Table 72. Roche Specialty Pharmaceutical Product
Table 73. Roche Revenue in Specialty Pharmaceutical Business (2018-2024) & (US$ Million)
Table 74. Roche Recent Developments
Table 75. Amgen Company Details
Table 76. Amgen Business Overview
Table 77. Amgen Specialty Pharmaceutical Product
Table 78. Amgen Revenue in Specialty Pharmaceutical Business (2018-2024) & (US$ Million)
Table 79. Amgen Recent Developments
Table 80. AbbVie Company Details
Table 81. AbbVie Business Overview
Table 82. AbbVie Specialty Pharmaceutical Product
Table 83. AbbVie Revenue in Specialty Pharmaceutical Business (2018-2024) & (US$ Million)
Table 84. AbbVie Recent Developments
Table 85. Novo Nordisk Company Details
Table 86. Novo Nordisk Business Overview
Table 87. Novo Nordisk Specialty Pharmaceutical Product
Table 88. Novo Nordisk Revenue in Specialty Pharmaceutical Business (2018-2024) & (US$ Million)
Table 89. Novo Nordisk Recent Developments
Table 90. Johnson & Johnson Company Details
Table 91. Johnson & Johnson Business Overview
Table 92. Johnson & Johnson Specialty Pharmaceutical Product
Table 93. Johnson & Johnson Revenue in Specialty Pharmaceutical Business (2018-2024) & (US$ Million)
Table 94. Johnson & Johnson Recent Developments
Table 95. Sanofi-Aventis Company Details
Table 96. Sanofi-Aventis Business Overview
Table 97. Sanofi-Aventis Specialty Pharmaceutical Product
Table 98. Sanofi-Aventis Revenue in Specialty Pharmaceutical Business (2018-2024) & (US$ Million)
Table 99. Sanofi-Aventis Recent Developments
Table 100. Merck Company Details
Table 101. Merck Business Overview
Table 102. Merck Specialty Pharmaceutical Product
Table 103. Merck Revenue in Specialty Pharmaceutical Business (2018-2024) & (US$ Million)
Table 104. Merck Recent Developments
Table 105. Eli Lilly Company Details
Table 106. Eli Lilly Business Overview
Table 107. Eli Lilly Specialty Pharmaceutical Product
Table 108. Eli Lilly Revenue in Specialty Pharmaceutical Business (2018-2024) & (US$ Million)
Table 109. Eli Lilly Recent Developments
Table 110. Novartis Company Details
Table 111. Novartis Business Overview
Table 112. Novartis Specialty Pharmaceutical Product
Table 113. Novartis Revenue in Specialty Pharmaceutical Business (2018-2024) & (US$ Million)
Table 114. Novartis Recent Developments
Table 115. 3sbio Company Details
Table 116. 3sbio Business Overview
Table 117. 3sbio Specialty Pharmaceutical Product
Table 118. 3sbio Revenue in Specialty Pharmaceutical Business (2018-2024) & (US$ Million)
Table 119. 3sbio Recent Developments
Table 120. Changchun High Tech Company Details
Table 121. Changchun High Tech Business Overview
Table 122. Changchun High Tech Specialty Pharmaceutical Product
Table 123. Changchun High Tech Revenue in Specialty Pharmaceutical Business (2018-2024) & (US$ Million)
Table 124. Changchun High Tech Recent Developments
Table 125. CP Guojian Pharmacy Company Details
Table 126. CP Guojian Pharmacy Business Overview
Table 127. CP Guojian Pharmacy Specialty Pharmaceutical Product
Table 128. CP Guojian Pharmacy Revenue in Specialty Pharmaceutical Business (2018-2024) & (US$ Million)
Table 129. CP Guojian Pharmacy Recent Developments
Table 130. Biotech Pharma Company Details
Table 131. Biotech Pharma Business Overview
Table 132. Biotech Pharma Specialty Pharmaceutical Product
Table 133. Biotech Pharma Revenue in Specialty Pharmaceutical Business (2018-2024) & (US$ Million)
Table 134. Biotech Pharma Recent Developments
Table 135. Gelgen Biopharma Company Details
Table 136. Gelgen Biopharma Business Overview
Table 137. Gelgen Biopharma Specialty Pharmaceutical Product
Table 138. Gelgen Biopharma Revenue in Specialty Pharmaceutical Business (2018-2024) & (US$ Million)
Table 139. Gelgen Biopharma Recent Developments
Table 140. Innovent Company Details
Table 141. Innovent Business Overview
Table 142. Innovent Specialty Pharmaceutical Product
Table 143. Innovent Revenue in Specialty Pharmaceutical Business (2018-2024) & (US$ Million)
Table 144. Innovent Recent Developments
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Specialty Pharmaceutical Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Specialty Pharmaceutical Market Share by Type: 2022 VS 2029
Figure 3. Antibody Features
Figure 4. Hormone Features
Figure 5. Growth Factors Features
Figure 6. Other Features
Figure 7. Global Specialty Pharmaceutical Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Specialty Pharmaceutical Market Share by Application: 2022 VS 2029
Figure 9. Tumor Case Studies
Figure 10. Diabetes Case Studies
Figure 11. Cardiovascular Case Studies
Figure 12. Hemophilia Case Studies
Figure 13. Other Case Studies
Figure 14. Specialty Pharmaceutical Report Years Considered
Figure 15. Global Specialty Pharmaceutical Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 16. Global Specialty Pharmaceutical Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Specialty Pharmaceutical Market Share by Region: 2022 VS 2029
Figure 18. Global Specialty Pharmaceutical Market Share by Players in 2022
Figure 19. Global Top Specialty Pharmaceutical Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Specialty Pharmaceutical as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by Specialty Pharmaceutical Revenue in 2022
Figure 21. North America Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. North America Specialty Pharmaceutical Market Share by Type (2018-2029)
Figure 23. North America Specialty Pharmaceutical Market Share by Application (2018-2029)
Figure 24. North America Specialty Pharmaceutical Market Share by Country (2018-2029)
Figure 25. United States Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Specialty Pharmaceutical Market Size YoY (2018-2029) & (US$ Million)
Figure 28. Europe Specialty Pharmaceutical Market Share by Type (2018-2029)
Figure 29. Europe Specialty Pharmaceutical Market Share by Application (2018-2029)
Figure 30. Europe Specialty Pharmaceutical Market Share by Country (2018-2029)
Figure 31. Germany Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. France Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. U.K. Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Italy Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Russia Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Nordic Countries Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. China Specialty Pharmaceutical Market Size YoY (2018-2029) & (US$ Million)
Figure 38. China Specialty Pharmaceutical Market Share by Type (2018-2029)
Figure 39. China Specialty Pharmaceutical Market Share by Application (2018-2029)
Figure 40. Asia Specialty Pharmaceutical Market Size YoY (2018-2029) & (US$ Million)
Figure 41. Asia Specialty Pharmaceutical Market Share by Type (2018-2029)
Figure 42. Asia Specialty Pharmaceutical Market Share by Application (2018-2029)
Figure 43. Asia Specialty Pharmaceutical Market Share by Region (2018-2029)
Figure 44. Japan Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. South Korea Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. China Taiwan Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Southeast Asia Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. India Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Australia Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Size YoY (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Share by Type (2018-2029)
Figure 52. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Share by Application (2018-2029)
Figure 53. Middle East, Africa, and Latin America Specialty Pharmaceutical Market Share by Country (2018-2029)
Figure 54. Brazil Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Mexico Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Turkey Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Israel Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. GCC Countries Specialty Pharmaceutical Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. Pfizer Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2024)
Figure 61. Roche Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2024)
Figure 62. Amgen Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2024)
Figure 63. AbbVie Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2024)
Figure 64. Novo Nordisk Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2024)
Figure 65. Johnson & Johnson Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2024)
Figure 66. Sanofi-Aventis Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2024)
Figure 67. Merck Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2024)
Figure 68. Eli Lilly Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2024)
Figure 69. Novartis Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2024)
Figure 70. 3sbio Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2024)
Figure 71. Changchun High Tech Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2024)
Figure 72. CP Guojian Pharmacy Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2024)
Figure 73. Biotech Pharma Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2024)
Figure 74. Gelgen Biopharma Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2024)
Figure 75. Innovent Revenue Growth Rate in Specialty Pharmaceutical Business (2018-2024)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries